George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetards Regulatory News (PEG)

Share Price Information for Petards (PEG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.75
Bid: 7.50
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 0.50 (6.667%)
Open: 7.75
High: 7.75
Low: 7.75
Prev. Close: 7.75
PEG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Feb 2021 07:00

RNS Number : 6890O
Petards Group PLC
11 February 2021
 

 

Petards Group plc

("Petards", the "Group" or the "Company")

 

Trading Update

 

Petards Group plc (AIM: PEG) the AIM listed Petards, the AIM quoted software developer of advanced security and surveillance systems, announces a trading update for the year ended 31 December 2020.

 

Trading Update:

 

As reported in September 2020, trading was proving extremely challenging which continued to be the case for the remainder of the year. This was particularly pertinent in respect of our eyeTrain operations for which customer scheduling was subject to change and deferral at very short notice, exacerbating the impact on revenue and delays in placement of new customer orders. On a brighter note, one of those delayed orders, for £1.3m was placed in October and will be delivered in the first quarter of 2021.

 

The planned reorganisation of eyeTrain activities I referred to in 2019, was a major priority in 2020, re-aligning the cost base following the substantial completion of the large software engineering developments that have been a feature of recent years. To put this into perspective, this enabled the Group to reduce its eyeTrain workforce by 40% during the course of the year while incurring substantial exceptional costs which will be recognised in the results for 2020. These actions will preserve future cash and improve operational efficiency thereby providing a better focus for future business.

 

We have recently created a virtual Petards Technology Centre to capitalise upon the wider Group's technical and development expertise. Our strategic objective is to enhance eyeTrain's technically advanced on-train sensing systems. This is envisaged to be achieved through use of "best of breed" third party applications, particularly those related to data capture, transmission and analytics.

 

While the Group's defence activities have had a moderately profitable year, they too were affected by customer agreed supplier delivery schedule changes with £0.5m of revenue being delayed into 2021 impacting profitability for 2020.

 

QRO had a record year, trading profitably and growing revenues by 35% having acquired the NASBox product line in April 2020. The year culminated in it securing its largest ever order (£0.8m) in December 2020 for a UK police force, the majority of which will be delivered in the first half of 2021.

 

RTS our real time safety critical rail infrastructure software business has performed well since its acquisition and maintained a similar level of profitably in 2020 compared with the prior year. Its future revenues are underpinned having in May 2020 secured the 4-year renewal of a significant software support contract that now runs until April 2024. The digitalisation of rail infrastructure processes provides growth opportunities for RTS, and we are planning additional investment in software to capitalise on these and add value to the business.

 

The Group expects to report, subject to audit, revenue of approximately £13m for the year (2019: £15.7m) and a slightly improved result compared with the prior year at the adjusted EBITDA level (2019: £0.3m loss). After amortisation, depreciation, reorganisation and financing charges, the Group expects, subject to audit, to report a loss before tax similar to that of 2019.

 

Closing year end cash balances were £2.2m (2019: £0.8m) and the Company has an unused and unutilised £0.75m revolving credit facility with its bank whose term runs until June 2022. Debt at the year-end was £1.0m (2019: £1.4m), including right-of-use asset liabilities of £0.4m (2019: £0.5m), resulting in net cash at 31 December 2020 of £1.2m (2019: £0.5 net debt). During the second quarter of 2020 the Group utilised the UK Government's VAT deferment scheme under which £0.36m of VAT payments have been deferred to 2021. The Group continued making its bank loan repayments as they fell due with £0.25m being repaid in the year.

 

The year-end order book stood at over £12m of which £10m is currently scheduled for delivery in 2021 with a weighting to the first half of the year.

 

In March 2020, the Group implemented a pandemic action plan taking all practical precautions, ensuring safe working conditions were in place for its employees, customers and suppliers. Consequently, all our sites have remained open for business since that time. The action plan also focussed on cash generation resulting in a much stronger cash position at year end.

 

Over the past five years we have acquired two relatively small businesses which have both proven very successful. As well as continuing to build upon these and the Group's other activities, the current economic conditions are presenting good quality acquisition opportunities, particularly in the privately owned sector. While any such acquisition would have a material impact on the size of the Group and its earnings capabilities, it would also add scale to the Group.

 

Against a background of the difficulties encountered by ourselves and our customers due to the impact and disruption caused by Covid-19, the Board consider the results for the year represent a credible performance. However, we believe that the benefits arising from the restructured eyeTrain business and the establishment of the Petards Technology Centre, places the Group in much stronger position for 2021 and beyond.

 

While it is presently too early in the year to re-instate market guidance, the Board is cautiously hopeful of improved results in 2021.

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

Contacts:

 

Petards Group plc

www.petards.com

 

Raschid Abdullah, Chairman

Mb: 07768 905 004

 

 

WH Ireland Limited, Nomad and Joint Broker

www.whirelandplc.com

 

Mike Coe / Chris Savidge

Tel: 0117 945 3470

 

 

Hybridan LLP, Joint Broker

www.hybridan.com

Claire Louise Noyce

 

Tel: 020 3764 2341

claire.noyce@hybridan.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUROWRAKUUAAR
Date   Source Headline
23rd Feb 20247:00 amRNSHolding(s) in Company
19th Feb 20247:00 amRNSContract Win
14th Feb 20247:00 amRNSContract Extension
30th Jan 20247:00 amRNSContract Win
25th Jan 20247:00 amRNSTrading Update
4th Jan 20245:40 pmRNSHolding(s) in Company
3rd Jan 20245:21 pmRNSHolding(s) in Company
19th Dec 202310:55 amRNSDirectorate Change
14th Dec 202311:24 amRNSHolding(s) in Company
13th Dec 202311:43 amRNSHolding(s) in Company
7th Dec 20234:19 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSDirector Appointment
26th Sep 20237:00 amRNSHalf-year Report
14th Jun 20232:46 pmRNSResult of AGM
26th May 202312:26 pmRNSHolding(s) in Company
19th May 20233:08 pmRNSPosting of Annual Report and Notice of AGM
9th May 20237:00 amRNSFinal Results
1st Feb 20237:00 amRNSDirector Appointment
16th Jan 20232:56 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSHalf-year Report
8th Jun 20222:58 pmRNSResult of AGM
13th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
3rd Dec 20212:33 pmRNSHolding(s) in Company
30th Nov 20217:00 amRNSTransaction in Own Shares
29th Nov 20219:05 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
9th Nov 20212:56 pmRNSHolding(s) in Company
23rd Sep 20217:00 amRNSHalf-year Report
22nd Jul 20212:40 pmRNSResult of AGM
1st Jul 20217:00 amRNSContract Award
28th Jun 20217:00 amRNSPosting of Accounts and Notice of AGM
24th Jun 20217:00 amRNSContract
28th May 20217:00 amRNSFinal Results
11th Feb 20217:00 amRNSTrading Update
8th Jan 20217:00 amRNSStmnt re Share Price Movement
9th Dec 20207:00 amRNSContract win
21st Oct 20207:00 amRNSContract win
14th Oct 20207:00 amRNSContract Win
24th Sep 20207:00 amRNSInterim Results
3rd Aug 20207:00 amRNSeyeCraft360 British Army trial success
24th Jul 20204:36 pmRNSHolding(s) in Company
23rd Jul 202011:32 amRNSResult of AGM
26th Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
18th Jun 20207:00 amRNSFinal Results
27th May 20209:54 amRNSServices Support Agreement
12th May 20207:00 amRNSServices Support Agreement
7th May 20207:00 amRNSAcquisition of New Product Line
28th Apr 202011:10 amRNSHolding(s) in Company
24th Apr 20207:00 amRNSCOVID-19 Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.